<PAGE>
                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                                   FORM 10-Q

                Quarterly Report Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

                    For the Quarter Ended September 30, 1996

                           Commission File No. 0-26288

                             CONTOUR MEDICAL, INC.
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

           Nevada                                      77-0163521
------------------------------             ----------------------------------
(State or Other Jurisdiction of           (IRS Employer Identification Number)
Incorporation or Organization)

                                3340 Scherer Drive
                          St. Petersburg, Florida 33716
                     ----------------------------------------
                     (Address of Principal Executive Offices)

                                (813) 572-0089
               ----------------------------------------------------
               (Registrant's Telephone Number, Including Area Code)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such report(s), and (2) has been subject to such filing
requirements for the past 90 days.

                              Yes [ X ]   No [   ]

There were 5,946,793 shares of the Registrant's $.001 par value Common Stock
outstanding as of November 14, 1996.
<PAGE>
                             CONTOUR MEDICAL, INC.

                                   FORM 10-Q

                                     INDEX
                                     -----

Part I.  Financial Information
------   ---------------------

Item 1.  Financial Statements                                            Page

         Consolidated Balance Sheets as of September 30, 1996
         and June 30, 1996                                                3-4

         Consolidated Statements of Operations for the Three
         Months Ended September 30, 1996 and 1995                        5  

         Consolidated Statements of Stockholders Equity                   6-7
         Three Months Ended September 30, 1996

         Consolidated Statements of Cash Flows for the
         Three Months Ended September 30, 1996 and 1995                   8-9
 
         Notes to Consolidated Financial Statements                      10-15

Item 2.  Management's Discussion and Analysis of Financial 
         Condition and Results of Operations                             16-17

Part II. Other Information
-------  -----------------

Item 1.  Legal Proceedings                                                18

Item 2.  Changes in Securities                                            18

Item 3.  Defaults Upon Senior Securities                                  18

Item 4.  Submission of Matters to a Vote of Security Holders              18

Item 5.  Other Information                                                18

Item 6.  Exhibits and Reports on Form 8-K                                 18

                               -2-
<PAGE>
              CONTOUR MEDICAL, INC. AND SUBSIDIARIES
                   Consolidated Balance Sheets

                                            September 30,    June 30,
                                                1996           1996
                                            ------------    ----------
                                             (Unaudited)
ASSETS

Current:
  Cash                                      $   400,489     $  146,219
  Accounts receivable - trade  
    Related parties (Note 4)                  2,027,499      1,918,000
    Other                                     9,318,620      2,527,676
  Inventories (Note 5)                        6,368,222      2,876,792
  Refundable income taxes                        21,406         21,406
  Prepaid expenses and other                    592,200         51,519
  Due from parent (Note 4)                      755,333        618,897
                                            -----------     ----------
      Total Current Assets                   19,483,769      8,160,509
                                            -----------     ----------
Property and Equipment, less
accumulated depreciation (Note 6)             1,823,880      1,223,195
                                            -----------     ----------
Other Assets:

  Goodwill, net of accumulated amortization   9,310,730      1,286,165
  Deposit on equipment                          503,018        416,184
  Other                                         130,188        172,215
                                            -----------     ----------
      Total Other Assets                      9,943,936      1,874,564
                                            -----------     ----------
                                            $31,251,585    $11,258,268

   See accompanying notes to consolidated financial statements.

                               -3-
<PAGE>
              CONTOUR MEDICAL, INC. AND SUBSIDIARIES
                   Consolidated Balance Sheets

                                            September 30,     June 30,
                                                1996            1996
                                            -------------   -----------
                                             (Unaudited)
LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:
  Accounts payable                           $ 3,345,228    $ 2,036,652
  Accrued expenses                               920,430        366,716
  Current maturities of long-term
   debt (Note 7)                              11,099,183      1,825,193
                                              ----------     ----------
      Total Current Liabilities               15,364,841      4,228,561

Long-term debt, less current
maturities (Note 7)                            4,152,739      1,352,937
                                              ----------     ----------
      Total Liabilities                       19,517,580      5,581,498
                                              ----------     ----------
Convertible debentures, 9% interest
due monthly through July 1, 2003               5,000,000             --
                                              ----------     ----------
Stockholders' Equity:
  Preferred stock - Series A conver-
   tible, $.001 par value, shares
   authorized 1,265,000; issued and
   outstanding 185,000 and 600,000
   respectively, at aggregate 
   liquidation preference                        875,400      2,528,000
  Common stock $.001 par - shares 
   authorized 76,000,000; issued and
   outstanding 5,946,793 and 5,214,223
   respectively, (net of $765 discount)            5,182          4,449
  Additional paid-in capital                   5,196,469      2,911,696
  Retained earnings                              656,954        232,625
                                              ----------     ----------
      Total stockholders' equity               6,734,005      5,676,770

                                             $31,251,585    $11,258,268

   See accompanying notes to consolidated financial statements.

                               -4-
<PAGE>
              CONTOUR MEDICAL, INC. AND SUBSIDIARIES
              Consolidated Statements of Operations

                                                Three Months Ended
                                                    (Unaudited)
                                           September 30,    September 30,
                                                1996             1995
                                            ------------     ------------ 
SALES                                       $12,912,530      $2,238,129

COST OF SALES                                 9,073,535       1,589,072
                                            ------------     ----------        
GROSS PROFIT                                  3,838,995         649,057

OPERATING EXPENSES                            2,937,158         489,601

OTHER INCOME (EXPENSE)                         (204,716)          3,088 
                                            ------------     ----------
INCOME BEFORE INCOME TAXES                      697,121         162,544

INCOME TAX EXPENSE                              265,392          55,265
                                            ------------     ----------
NET INCOME                                  $   431,729      $  107,279

NET INCOME PER COMMON SHARE                 $       .07      $      .02

WEIGHTED AVERAGE NUMBER OF COMMON
SHARES                                        5,716,891       4,571,677

   See accompanying notes to consolidated financial statements.

                               -5-
<PAGE>
              CONTOUR MEDICAL, INC. AND SUBSIDIARIES
          Consolidated Statement of Stockholders' Equity

                                                           Additional   
                                    Common Stock            Paid-in     
                                  Shares     Amount         Capital     
                                 ---------   ------        ----------   
Balance, June 30, 1996           5,214,223   $4,449        $2,911,696   
         
Exercise of common stock
 warrants                          296,820      297           625,209   

Conversions of preferred 
stock                              415,000      415         1,659,564  

Conversion dividend                 20,750       21

Preferred dividends in
 arrears                                --       --                --   

Net income                              --       --                --   

Balance, September 30, 1996      5,946,793   $5,182        $5,196,469

        See accompanying notes to consolidated financial statements.

                               -6-
<PAGE>
                    CONTOUR MEDICAL, INC. AND SUBSIDIARIES
                Consolidated Statement of Stockholders' Equity

                                    Convertible                      
                                   Preferred Stock                    
                                 -----------------          Retained 
                                Shares       Amount         Earnings
                               --------     --------       -----------
Balance, June 30, 1996          600,000   $2,528,000         $232,625
                                                                  
Exercise of common stock
 warrants                            --           --               --
      
Conversions of preferred 
stock                          (415,000)  (1,660,000)              --

Preferred dividends in
 arrears                                       7,400          (7,400)

Net income                                                    431,729 

Balance, September 30, 1996       185,000   $  875,400       $656,954

        See accompanying notes to consolidated financial statements.

                               -7-
<PAGE>
                    CONTOUR MEDICAL, INC. AND SUBSIDIARIES
                    Consolidated Statements of Cash Flows

                                                Three Months Ended
                                                    (Unaudited)
                                           September 30,    September 30,
                                               1996             1995 
                                            ----------       ----------  
CASH FLOWS FROM OPERATING ACTIVITIES:

Net income                                  $  431,729        $ 107,279

Adjustments to reconcile net income
 to net cash provided (used) by
 operating activities:

   Depreciation and Amortization               163,661           33,076
   Tax benefit from NOL                             --           55,265
     (Increase) decrease in accounts
       receivable                           (6,900,443)        (123,127)
     (Increase) decrease in inventories     (3,491,430)        (204,788)
     (Increase) decrease in other 
       current assets and other assets      (8,523,219)        ( 84,713)
     Increase (decrease) in accounts
       payable                               1,308,576         ( 16,227)
     Increase (decrease) in accrued
       expenses and other liabilities          553,714           15,103
                                           ------------       ---------- 
       Net cash provided by operating
         activities                        (16,457,412)        (218,132)

CASH FLOW FROM INVESTING ACTIVITIES:

  Deposit on equipment                     (    86,834)              --
  Acquisition of equipment                 (   720,106)        ( 95,921)
  Decrease (increase) in due 
     from parent                           (   136,436)         150,000
                                           -------------       ---------
        Net cash provided(used) by
          investing activities             (   943,376)         $54,079

   See accompanying notes to consolidated financial statements.

                               -8-
<PAGE>
              CONTOUR MEDICAL, INC. AND SUBSIDIARIES
              Consolidated Statements of Cash Flows

                                                 Three Months Ended
                                                    (Unaudited)
                                            September 30,    September 30,
                                                1996             1995     
                                            ------------     ------------
CASH FLOWS FROM FINANCING ACTIVITIES:

Acquisition Notes Issued                    $ 10,850,000      $       --
Convertible Debentures Issued                  5,000,000              --
Net borrowing on loans                         1,179,552         126,135
Exercise of warrants                             625,506          50,000
                                            -------------     -----------
     Net cash provided (used) by 
          financing activities                17,655,058         176,135
                                            -------------     -----------
NET INCREASE (DECREASE) IN CASH                  254,270          12,082 

CASH BEGINNING OF PERIOD                         146,219          96,235
                                            -------------     -----------
CASH END OF PERIOD                          $    400,489       $ 108,317


SUPPLEMENTAL DISCLOSURE OF CASH
FLOW INFORMATION AND NON-CASH
ACTIVITIES:

  Cash paid for interest                    $    199,255      $   28,890

   See accompanying notes to consolidated financial statements.

                               -9-
<PAGE>
              CONTOUR MEDICAL, INC. AND SUBSIDIARIES
      Notes to Consolidated Financial Statements (Unaudited)

1.   BASIS OF PRESENTATION
     ---------------------
The accompanying unaudited condensed financial statements have been prepared
in accordance with generally accepted accounting principles for interim
financial information.  Accordingly, they do not include all of the
information and footnotes required by generally accepted accounting principles
for complete financial statements.  In the opinion of management, all
adjustments, consisting of normal recurring accruals, considered necessary for
a fair presentation have been included.  It is suggested that these condensed
financial statements be read in conjunction with the financial statements and
notes thereto included in the June 30, 1996, audited financial statements for
Contour Medical, Inc.  The results of operations for the periods ended
September 30, 1996 and 1995 are not necessarily indicative of the operating
results for the full year.

The consolidated financial statements include the accounts of Contour Medical,
Inc. ("CMI") and its wholly-owned subsidiaries, Contour Fabricators, Inc.
("CFI"), Contour Fabricators of Florida, Inc. ("CFFI") and, since March 1,
1996, AmeriDyne Corporation ("AmeriDyne"), and effective July 1, 1996 Atlantic
Medical Supply Company, Inc. ("Atlantic") collectively referred to as the
Company.  All material intercompany accounts and transactions have been
eliminated.  CMI is a majority-owned subsidiary of Retirement Care Associates,
Inc. ("Parent").

On March 1, 1996, Contour Medical, Inc. acquired AmeriDyne through a merger
which was accounted for as a purchase.  The Company issued 369,619 shares of
its common stock and paid $250,000 to the sole stockholder of AmeriDyne in
connection with this purchase.

On August 6, 1996, the Company acquired all of the outstanding stock of
Atlantic Medical Supply Company, Inc. ("Atlantic"), a distributor of
disposable medical supplies and a provider of third-party billing services to
the nursing home and home health care markets.  The acquisition was made
retroactively to July 1, 1996.  The Company paid $1.4 million in cash and
$10.5 million in promissory notes for all of the outstanding stock of
Atlantic.  The promissory notes bear interest at 7% per annum and are due in
full on January 10, 1997.  In the event of a default in the payment of the
promissory notes, they are convertible into shares of common stock of Parent.

In addition, on August 9, 1996, the Company acquired the remaining minority
interest of Facility Supply, Inc., a majority owned subsidiary of Atlantic. 
The acquisition was made retroactively to July 1, 1996.  The Company paid
$50,000 in cash and $350,000 in promissory notes for the remaining outstanding
stock of Facility Supply, Inc.  The promissory notes bear interest at 7% per
annum and are due in full on January 10, 1997.  In the event of a default in
the payment of the promissory notes, they are convertible into shares of
common stock of Parent.

2.   CHANGE IN METHOD OF ACCOUNTING FOR TAXES AND INCOME
     ---------------------------------------------------
Effective January 1, 1993, the Company adopted Statement of Financial
Accounting Standards No. 109, "Accounting for Income Taxes" ("FAS 109") which
requires recognition of estimated income taxes payable or refundable on income
tax returns for the current year and for the estimated future tax effect 
                               -10-
<PAGE>
attributable to temporary differences and carry forwards.  Measurement of
deferred income tax assets being reduced by available tax benefits not
expected to be realized.

3.   CHANGE IN YEAR END
     ------------------
The Company changed its fiscal year end from December 31 to June 30 during
1995. Atlantic also changed its fiscal year end from December 31 to June 30
during 1996.

4.   RELATED PARTY TRANSACTIONS
     --------------------------
During 1995, the Company began distributing medical supplies to health care
facilities owned, leased or managed by the Parent. Sales to these facilities
approximated $1,836,000 for the three month period ended September 30, 1996,
and $746,000 in 1995. Trade accounts receivable of $2,027,000 and $1,918,000
were outstanding as of September 30, 1996 and June 30, 1996, respectively, as
related to health care facility sales to the Parent.  Additionally, the
Company had an outstanding loan receivable due from its Parent of
approximately $755,000 at September 30, 1996, which is due within 45 days of
advance with interest at prime and $619,000 at June 30, 1996, which is due on
demand with no stated interest rate.

5.   INVENTORIES
     -----------
Inventories are summarized as follows:

                                       September 30,      June 30,
                                           1996            1996
                                        ----------      ----------
      Raw Materials                     $  284,463     $  330,699 
      Work in process                       70,604         96,647 
      Finished goods                     6,013,155      2,449,446 
                                        ----------      ----------
                                        $6,368,222      $2,876,792         

All inventories are pledged as collateral.

                               -11-
<PAGE>
6.   PROPERTY AND EQUIPMENT
     ----------------------
Property and equipment consist of the following:

                                            September 30,       June 30,
                            Useful Lives        1996              1996
                            ------------     ----------        ----------
Land & Land Improvements        --               59,842        $   50,000
Building                     5-45 years         596,247           596,247
Computer Equipment           3-7 years       $1,010,445            --
Machinery and equipment      3-7  years       2,208,217         1,798,520
Furniture and fixtures       5-7  years         222,920           146,536
Leasehold improvements       5    years         290,563           251,352
Vehicles                     3-5  years         188,202            72,245
                                             ----------        ----------
                                              4,576,436         2,914,900
Less accumulated depreciation                 2,752,556         1,691,705
                                             ----------        ----------
                                             $1,823,880        $1,223,195

Certain property and equipment are pledged as collateral (see Notes 7 and 8).

7.   NOTES PAYABLE
     ----------------------------
Notes payable at September 30, 1996 and June 30, 1996 consisted of the
following:
                                                  September 30,   June 30,
                                                      1996          1996
                                                   ----------   -----------
Note payable to sellers of Atlantic Medical
Supply Company, Inc. at 7%, principal and
interst due on January 10, 197, in event
of default convertible into common stock
of Parent                                          $10,500,000          --

Note payable to sellers of Facility
Supply, inc. at 7%, principal and
interest due on January 10, 1997, in
event of default convertible into common
stock of Parent                                        350,000          --

Note payable to bank, interest at prime plus
1% (9.25% at June 30, 1996), principal of 
$5,000 plus interest due monthly through 
June 2000, collateralized by equipment                 203,750  $  217,559

Note payable to bank, interest at prime plus
 .75% (9.00% at June 30, 1996) principal of
$7,605 plus interest due monthly through   
May 2000, collateralized by equipment and
real property                                          480,899     496,171

Mortgage payable to bank, bearing interest
at 8.58%, principal and interest of $6,793,
due monthly through December 2003, 
collateralized by equipment and real property          445,677     456,233

                               -12-
<PAGE>
Mortgage payable to bank, interest at prime
plus .75% (9.00% at June 30, 1996) principal
of $1,190 plus interest due monthly through
December 2000, collateralized by equipment
and real property                                       59,522      64,284

Borrowings under $7,000,000 line of credit, 
interest at 30 day libor plus 200bp (7.44% 
at September 30, 1996), payable monthly, 
collateralized by accounts receivable, and
inventory.  Principal due October 31, 1997           2,994,105          --

Borrowings under $100,000 line of credit, 
interest at prime plus .75% (9.00% 
at June 30, 1996), payable monthly, 
collateralized by accounts receivable, 
inventory, equipment, and real property                     --      65,000

Note payable to bank, interest at 8.75%
principal and interest at $1,282 due monthly 
through April 2001, collateralized by equipment         57,903      60,436

Borrowings under $500,000 line of credit,
interest at prime plus .25% (8.5% at June
30, 1996) payable monthly, collateralized  
by accounts receivable, inventory and  
equipment, and guarantees by Retirement                    
Care Associates, Inc.                                       --     433,535

Note payable to leasing institution, 
interest at 14.6%, monthly installments of 
$309 plus sales tax. Matures June 1997, 
collateralized by computer equipment                     2,079       2,924     
               
Note payable to equipment company, interest at
11%, monthly installments of $533 including 
interest.  Matures December 1997,     
collateralized by equipment                              7,436       8,805
  
Note payable to stockholder, interest at 10%,
principal and interest of $5,693, due monthly
through March 1999                                     150,551     163,646
 
Note payable to bank, interest at 9%, principal
and interest of $3,600 due monthly through May
1997, collateralized by accounts receivable, 
inventory, furniture, fixtures, equipment,                 
machinery, bank accounts, and guarantees of                      
Parent                                                      --      38,924

Note payable to bank, interest at 9%, principal
and interest of $5,266 due monthly through 
October 1997, collateralized by accounts 
receivable, inventory, furniture, fixtures, 
equipment, machinery, bank accounts, and 
guarantees of Parent                                        --     212,613  

                               -13-
<PAGE>
Borrowings under $975,000 line of credit, interest
at prime plus 1.25% (9.5% at June 30, 1996).  
Principal is due on demand but no later than May
15, 1997.  Collateralized by accounts receivable,
inventory, furniture, fixtures, equipment, 
machinery, bank accounts, and guarantees of 
Parent                                                      --     958,000 
                                                   -----------  ----------
                                                   $15,251,922  $3,178,130

Less current maturities                             11,099,183   1,825,193
                                                   -----------  ----------
                                                   $ 4,152,739  $1,352,937

Certain of the above agreements contain financial and operating covenants,
including requirements that the Company maintain certain net worth levels and
satisfy current and debt-to-net worth ratios.  The Company was in compliance
with all debt covenants as of September 30, 1996.

The aggregate maturities of long-term debt are as follows as of September 30,
1996:
 
               1997                         $ 11,099,183
               1998                            3,273,405
               1999                              303,777
               2000                              491,884
               2001                               83,674              

SFAS No. 107, "Disclosure About Fair Value of Financial Instruments," requires
that the Company disclose estimated fair values for its financial instruments. 
Fair value is defined as the price at which a financial instrument could be
liquidated in an orderly manner over a reasonable time period under present
market conditions.  The rates of the Company's fixed obligations approximate
those rates of the adjustable loans.  Therefore, the fair value of those loans
has been estimated to be approximately equal to their carrying value.

COMMITMENTS AND CONTINGENCIES:

The company is obligated under various noncancelable leases for equipment and
office space.  Future minimum lease commitments under operating leases were as
follows as of September 30, 1996.

               1997                         $  389,974
               1998                            412,224
               1999                            385,974
               2000                            307,224
               2001                            305,062
     
EMPLOYMENT AGREEMENT - The Company has entered into an employment agreement
with a key executive for a five-year period ending June 1998. The agreement
provides for annual base compensation of $100,000.

LITIGATION - During 1994, the Company was a defendant in an employment injury
lawsuit filed by one of its employees.  The Company settled this dispute for
approximately $30,000.

                               -14-
<PAGE>
The Company was a defendant in a lawsuit filed by one of its former employees
for wrongful discharge of employment.  During the year ended December 31,
1993, the Company settled this dispute for $85,000.

8.   INCOME TAXES:

Income taxes are provided based on the liability method of accounting pursuant
to Statement of Financial Accounting Standards No. 109, "Accounting for Income
Taxes."

9.   ACQUISITION:

Effective March 1, 1996, the Company acquired all of the outstanding common
stock of AmeriDyne Corporation ("AmeriDyne") for approximately $2.475 million
in cash and stock.  AmeriDyne distributes medical supplies to hospitals, 
clinics, physicians, pharmacies, nursing homes and other health care providers.

The purchase price exceeded the fair value of the net assets acquired by
approximately $1.3 million.  The acquisition was accounted for as a purchase. 
The resulting goodwill is being amortized on the straight-line basis over 40
years.  

On August 6, 1996, the Company acquired all of the outstanding stock of
Atlantic Medical Supply Company, Inc. ("Atlantic"), a distributor of
disposable medical supplies and a provider of third-party billing services to
the nursing home and home health care markets.  The acquisition was made
retroactively to July 1, 1996.  The Company paid $1.4 million in cash and
$10.5 million in promissory notes for all of the outstanding stock of 
Atlantic.  The promissory notes bear interest at 7% per annum and are due in
full on January 10, 1997.  In the event of a default in the payment of the
promissory notes, they are convertible into shares of common stock of Parent. 

The following unaudited pro forma consolidated results of operations presents
information as if the acquisitions had occurred at the beginning of the fiscal
year in 1995.  The pro forma information is provided for information purposes
only.  It is based on historical information and does not necessarily reflect
the results that would have occurred nor is it necessarily indicative of
future results of operations of the combined enterprise.

                                   Unaudited           Unaudited
                              Three Months Ended       Year Ended
                              September 30, 1995      June 30, 1996
                              ------------------      -------------
         Sales                  $ 10,430,697          $ 34,333,727
         Net Income                  590,841          $    585,784*
         Per share                      0.13          $       0.10

* Full year earnings reflect write down of approximately $1.1 million for
events occurring prior to July 1, 1995.

                               -15-
<PAGE>
ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS.

The following should be read in conjunction with the attached Financial
Statements and Notes thereto of the Company.

THREE MONTHS ENDED SEPTEMBER 30, 1996 COMPARED TO THREE MONTHS ENDED SEPTEMBER
30, 1995
-----------------------------------------------------------------------------

As a result of the factors discussed below, for the three months ended
September 30, 1996, the Company had net income of $431,729 compared to
$107,279 for the three months ended September 30, 1995.

Sales increased by $10,674,000 for the three months ended September 30, 1996
as compared to the three months ended September 30, 1995.  Approximately
$52,000 of this increase related to an increase in demand for the Company's
traditional product lines.  Approximately $3,226,000 of the increase resulted
from sales by AmeriDyne and approximately $7,396,000 in sales by Atlantic. 
AmeriDyne and Atlantic were acquired by the Company effective March 1, 1996,
and July 1, 1996, respectively.

Gross profit for the three months ended September 30, 1996, was $3,838,995 or
30% of sales, as compared to $649,057 or 29% of sales, for the same period of
the previous year.  The increase in gross profit as a percentage of sales is
primarily the result of higher gross profit margins on the products sold by
AmeriDyne and Atlantic.

Operating expenses for the three month period ending September 30, 1996, were
$2,937,158 as compared to $489,601 in 1995.  The operating expenses increased
approximately 600% as the result of the Atlantic and AmeriDyne acquisitions,
although as a percent of sales the increase represented only a 1% increase.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------
At September 30, 1996, the Company had $4,118,928 of working capital as
compared to $3,931,948 on June 30, 1996.  

Operating activities for the three months ended September 30, 1996, utilized
cash of $16,457,412 as compared to operating activities during the three
months ended September 30, 1995, which utilized cash of $218,132.  The
increased use of cash was primarily due to increases in inventory, accounts
receivable and other assets as a result of the Atlantic acquisition.

The cash flows used in investing activities of $943,376 during the three
months ended September 30, 1996, were a result of an advance of $136,000 to
the Company's Parent and by the use of $807,000 for the acquisition of
additional equipment and a deposit on equipment.

Cash flow of $17,655,058 was provided from financing activities in 1996,
whereas in 1995 cash flows from financing activities provided cash of
$176,135. During the three months ended September 30, 1996, $5,000,000 was
provided from debenture borrowings, $10,850,000 from promissory notes related
to the acquisition of Atlantic, and $625,506 was provided from the exercise of
warrants.

                               -16-
<PAGE>
The Company currently maintains a total of $7 million revolving line of credit
with its banks for short-term working capital needs.  As of September 30,
1996, $2,994,105 had been borrowed against these lines.  

On August 6, 1996, the Company acquired all of the outstanding stock of
Atlantic Medical Supply Company, Inc. ("Atlantic"), a distributor of
disposable medical supplies and a provider of third-party billing services to
the nursing home and home health care markets.  The acquisition was made
effective retroactively to July 1, 1996.  The Company paid $1,400,000 in cash
and promissory notes totaling $10,500,000 for the stock of Atlantic Medical,
and subsequently paid an additional $50,000 in cash and issued a promissory
note for $350,000 to acquire a minority interest in a subsidiary of Atlantic,
Facility Supply, Inc.   The promissory notes bear interest at 7% per annum and
are due in full on January 10, 1997.  In the event of a default in the payment
of the promissory notes, they are convertible into shares of common stock of
the Parent.  The cash for this transaction came from the $5 million debenture
placement that was completed on July 12, 1996.  The Company intends to pay the
promissory notes from the proceeds of an offering of the Company's securities
to be conducted by the Company.

The Company presently does not anticipate any commitments for material capital
expenditures.

SEASONALITY AND INFLATION
-------------------------
The Company's business is relatively consistent and stable on a monthly basis,
and has not indicated any seasonality over the prior three fiscal periods.

In addition, the Company does not believe that inflation has had a material
effect on its results from operations during the past three fiscal years. 
There can be no assurance, however, that the Company's business will not be
affected by inflation in the future.

                          PART II.  OTHER INFORMATION

Item 1.   Legal Proceedings - None.

Item 2.   Changes in Securities - None.

Item 3.   Defaults Upon Senior Securities - None.
          
Item 4.   Submission of Matters to a Vote of Security Holders - None.

Item 5.   Other Information - None.

Item 6.   Exhibits and Reports on Form 8-K

          (a)  Exhibit 27     Financial Data Schedule     Filed herewith
                                                          electronically

          (b)  Reports on Form 8-K.

The Company filed one Report on Form 8-K dated August 6, 1996, reporting
information under Item 2 - Acquisition or Disposition of Assets and Item 7 -
Financial Statements, Pro Forma Financial Information and Exhibits, concerning
the Company's acquisition of Atlantic Medical Supply Company, Inc.

                               -17-
<PAGE>
                             SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                    CONTOUR MEDICAL, INC.


Date:  November 14, 1996            By /s/ Donald F. Fox                        
                                           Donald F. Fox,
                                           President, Treasurer and 
                                           Chief Financial Officer

                               -18-
<PAGE>
                               EXHIBIT INDEX

EXHIBIT                                               METHOD OF FILING
-------                                        ------------------------------
  27.     Financial Data Schedule               Filed herewith electronically